Nemonapride, also known as YM-09151-2 and Emilace, is a dopamine D2/D3/D4 receptor antagonist for the treatment of schizophrenia.
ChEBI: N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide is a benzamide obtained by formal condensation of the carboxy group of 5-chloro-2-methoxy-4-(methylamino)benzoic acid with the amino group of 1-benzyl-2-methylpyrrolidin-3-amine. It is a N-alkylpyrrolidine, a member of benzamides, a member of monochlorobenzenes, a secondary amino compound, a monomethoxybenzene, a substituted aniline and a secondary carboxamide.
